https://doi.org/10.4081/reumatismo.2021.1374
Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases
Submitted: 25 November 2020
Accepted: 16 February 2021
Published: 19 April 2021
Accepted: 16 February 2021
Abstract Views: 4717
PDF: 1147
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can show musculoskeletal symptoms such as peripheral arthritis. In rare cases, peripheral arthritis can develop after the resolution of SARS-CoV-2. We present two cases of spondyloarthritis induced by SARS-CoV-2; one case with axial and peripheral spondyloarthritis and the other with peripheral spondyloarthritis. Both cases refer to Lebanese patients who were HLA-B27 positive. These two cases highlight the possible predisposition of HLA-B27 positive patients to the development of spondyloarthritis symptoms triggered by SARS-CoV-2.
Cipollaro L, Giordano L, Padulo J, et al. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020; 15: 178.
DOI: https://doi.org/10.1186/s13018-020-01702-w
Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020; 40: 823-.
DOI: https://doi.org/10.1007/s00296-020-04561-0
Alivernini S, Cingolani A, Gessi M, et al. Comparative analysis of synovial inflammation after SARS-CoV-2 infection. Ann Rheum Dis. 2020 [Epub ahead of print].
DOI: https://doi.org/10.1136/annrheumdis-2020-218315
Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020; 39: 2055-62.
DOI: https://doi.org/10.1007/s10067-020-05073-9
Parisi S, Borrelli R, Bianchi S, Fusaro E. Viral arthritis and COVID-19. Lancet Rheumatol. 2020; 2: e655-e7.
DOI: https://doi.org/10.1016/S2665-9913(20)30348-9
Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011; 377: 2127-37.
DOI: https://doi.org/10.1016/S0140-6736(11)60071-8
Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. N Engl J Med. 2016; 374: 2563-74.
DOI: https://doi.org/10.1056/NEJMra1406182
Moll JM, Haslock I, Macrae IF, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore). 1974; 53: 343-64.
DOI: https://doi.org/10.1097/00005792-197409000-00002
Jawad AS. Persistent arthritis after human parvovirus B19 infection. Lancet. 1993; 341: 494.
DOI: https://doi.org/10.1016/0140-6736(93)90247-E
Talarico R, Stagnaro C, Ferro F, et al. Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection. Lancet Rheumatol. 2020; 2: e518-e9.
DOI: https://doi.org/10.1016/S2665-9913(20)30216-2
Novelli L, Motta F, Ceribelli A, et al. A case of psoriatic arthritis triggered by SARS-CoV-2 infection. Rheumatology (Oxford). 2021; 60: e21-e3.
DOI: https://doi.org/10.1093/rheumatology/keaa691
Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2020 [Epub ahead of print].
DOI: https://doi.org/10.1002/jmv.26296
Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020; 6(2) [Epub ahead of print].
DOI: https://doi.org/10.1136/rmdopen-2020-001350
Danssaert Z, Raum G, Hemtasilpa S. Reactive Arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus. 2020; 12: e9698.
DOI: https://doi.org/10.7759/cureus.9698
Yokogawa N, Minematsu N, Katano H, Suzuki T. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2020 [Epub ahead of print].
DOI: https://doi.org/10.1136/annrheumdis-2020-218281
De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2020 [Epub ahead of print].
DOI: https://doi.org/10.1136/annrheumdis-2020-218520
Gunal EK, Sarvan FO, Kamali S, et al. Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine. 2008; 75: 299-302.
DOI: https://doi.org/10.1016/j.jbspin.2007.06.021
Bodur H, Ataman S, Akbulut L, et al. Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol. 2008; 27: 1119-25.
DOI: https://doi.org/10.1007/s10067-008-0877-1
Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: a review. J Adolesc Health. 2009; 44: 309-15.
DOI: https://doi.org/10.1016/j.jadohealth.2008.12.007
Londono J, Santos AM, Pena P, et al. Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns. BMJ Open. 2015; 5: e009092.
DOI: https://doi.org/10.1136/bmjopen-2015-009092
Paladini F, Taccari E, Fiorillo MT, et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum. 2005; 52: 3319-21.
DOI: https://doi.org/10.1002/art.21308
Awadia H, Baddoura R, Naman R, et al. Weak association between HLA-B27 and the spondylarthropathies in Lebanon. Arthritis Rheum. 1997; 40: 388-9.
DOI: https://doi.org/10.1002/art.1780400226
Supporting Agencies
NoneHow to Cite
El Hasbani, G., Jawad, A., & Uthman, I. (2021). Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases. Reumatismo, 73(1), 59–63. https://doi.org/10.4081/reumatismo.2021.1374
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.